Exercise Training in Chronic Chagas Cardiomyopathy: Promising Preliminary Evidence, but Long-term Large Clinical Trials Are Still Needed

Overview

Journal Int J Cardiol Heart Vasc

Date 2023 Oct 5

PMID 37794958

Authors

Flavia Mazzoli-Rocha

Mauro Felippe Felix Mediano

Affiliations

Soon will be listed here.

References

Laoutaris I, Adamopoulos S, Manginas A, Panagiotakos D, Kallistratos M, Doulaptsis C . Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol. 2012; 167(5):1967-72. DOI: 10.1016/j.ijcard.2012.05.019. View

Torres R, Correia D, Nunes M, Dutra W, Talvani A, Sousa A . Prognosis of chronic Chagas heart disease and other pending clinical challenges. Mem Inst Oswaldo Cruz. 2022; 117:e210172. PMC: 9172891. DOI: 10.1590/0074-02760210172. View

Carvalho T, Milani M, Ferraz A, da Silveira A, Herdy A, Hossri C . Brazilian Cardiovascular Rehabilitation Guideline - 2020. Arq Bras Cardiol. 2020; 114(5):943-987. PMC: 8387006. DOI: 10.36660/abc.20200407. View

Viana A, Vieira M, Mazzoli-Rocha F, Silva R, Frota A, Costa H . Comparative effects of a cardiovascular rehabilitation program on functional capacity in patients with chronic chagasic cardiomyopathy with or without heart failure. Disabil Rehabil. 2022; 45(1):51-56. DOI: 10.1080/09638288.2021.2024282. View

Calderon-Ramirez P, Fernandez-Guzman D, Caira-Chuquineyra B, Mamani-Garcia C, Medina H, Diaz-Arocutipa C . Exercise-based training programs for patients with chronic Chagas cardiomyopathy: A systematic review and -analysis. Int J Cardiol Heart Vasc. 2023; 48:101256. PMC: 10545933. DOI: 10.1016/j.ijcha.2023.101256. View

Rassi Jr A, Dias J, Marin-Neto J, Rassi A . Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart. 2009; 95(7):524-34. DOI: 10.1136/hrt.2008.159624. View

Ambrosetti M, Abreu A, Corra U, Davos C, Hansen D, Frederix I . Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021; 28(5):460-495. DOI: 10.1177/2047487320913379. View

Lima M, Rocha M, Nunes M, Sousa L, Costa H, Alencar M . A randomized trial of the effects of exercise training in Chagas cardiomyopathy. Eur J Heart Fail. 2010; 12(8):866-73. DOI: 10.1093/eurjhf/hfq123. View

Taylor R, Dalal H, McDonagh S . The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2021; 19(3):180-194. PMC: 8445013. DOI: 10.1038/s41569-021-00611-7. View

10.

Azambuja A, de Oliveira L, Sbruzzi G . Inspiratory Muscle Training in Patients With Heart Failure: What Is New? Systematic Review and Meta-Analysis. Phys Ther. 2020; 100(12):2099-2109. DOI: 10.1093/ptj/pzaa171. View

11.

Moncayo A, Silveira A . Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:17-30. DOI: 10.1590/s0074-02762009000900005. View

12.

Saraiva R, Mediano M, Mendes F, da Silva G, Veloso H, Sangenis L . Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care. World J Cardiol. 2022; 13(12):654-675. PMC: 8716970. DOI: 10.4330/wjc.v13.i12.654. View

13.

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2021; 29(1):5-115. DOI: 10.1093/eurjpc/zwab154. View

14.

Mendes F, Mediano M, de Castro E Souza F, Silva P, Carneiro F, de Holanda M . Effect of Physical Exercise Training in Patients With Chagas Heart Disease (from the PEACH STUDY). Am J Cardiol. 2020; 125(9):1413-1420. DOI: 10.1016/j.amjcard.2020.01.035. View